Home
>
National Drug Code (NDC)
>
SEROMYCIN
SEROMYCIN - 13845-1200-3 - (CYCLOSERINE)
Drug Information of SEROMYCIN
| Product NDC: | 13845-1200 |
| Proprietary Name: | SEROMYCIN |
| Non Proprietary Name: | CYCLOSERINE |
| Active Ingredient(s): | 250 mg/250mg & nbsp; CYCLOSERINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SEROMYCIN
| Product NDC: | 13845-1200 |
| Labeler Name: | Purdue GMP Center LLC dba The Chao Center |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA060593 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090301 |
Package Information of SEROMYCIN
| Package NDC: | 13845-1200-3 |
| Package Description: | 40 CAPSULE in 1 BOTTLE (13845-1200-3) > 250 mg in 1 CAPSULE (13845-1200-1) |
NDC Information of SEROMYCIN
| NDC Code | 13845-1200-3 |
| Proprietary Name | SEROMYCIN |
| Package Description | 40 CAPSULE in 1 BOTTLE (13845-1200-3) > 250 mg in 1 CAPSULE (13845-1200-1) |
| Product NDC | 13845-1200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CYCLOSERINE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20090301 |
| Marketing Category Name | ANDA |
| Labeler Name | Purdue GMP Center LLC dba The Chao Center |
| Substance Name | CYCLOSERINE |
| Strength Number | 250 |
| Strength Unit | mg/250mg |
| Pharmaceutical Classes |
